Hak David J, Schulz Kurt S, Khoie Behrang, Hazelwood Scott J
Denver Health/University of Colorado, 777 Bannock Street, MC 0188, Denver, CO 80204, USA.
J Orthop Sci. 2011 Jan;16(1):93-8. doi: 10.1007/s00776-010-0016-0. Epub 2011 Jan 25.
The purpose of this study was to evaluate the effect of Cox-2 administration on direct (primary) fracture healing.
A transverse tibial osteotomy was created in adult male rabbits and rigidly fixed in compression using a 2.7-mm dynamic compression plate. Animals were randomized to receive either rofecoxib (12.5 mg orally per day) or placebo. Animals were killed at 4 weeks and fracture healing assessed by mechanical testing.
There were no significant differences between the control and Cox-2 treated animals in terms of mechanical strength at 4 weeks. There was a high complication rate of peri-implant fractures during the daily medication administration.
The immediate administration of a Cox-2 specific inhibitor did not impair primary (direct) bone healing at the dose administered in this rabbit tibial osteotomy model.
本研究旨在评估给予环氧化酶-2(Cox-2)对直接(一期)骨折愈合的影响。
在成年雄性兔中制造胫骨横向截骨术,并使用2.7毫米动力加压钢板进行刚性加压固定。将动物随机分为两组,分别给予罗非昔布(每天口服12.5毫克)或安慰剂。在4周时处死动物,并通过力学测试评估骨折愈合情况。
在4周时,对照组和接受Cox-2治疗的动物在力学强度方面没有显著差异。在每日给药期间,植入物周围骨折的并发症发生率较高。
在本兔胫骨截骨术模型中,按所给剂量立即给予Cox-2特异性抑制剂不会损害一期(直接)骨愈合。